Faculty Opinions recommendation of The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer.
Cheng‐Ming Chiang(The University of Texas Southwestern Medical Center)
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
October 6, 2019
Cited by 0
Related Papers
IDR-targeting compounds suppress HPV genome replication via disruption of phospho-BRD4 association with DNA damage response factors
|Molecular Cell|2023|28
Faculty Opinions recommendation of TIP60 represses activation of endogenous retroviral elements.
|Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature|2018|0
Faculty Opinions recommendation of ZFAT binds to centromeres to control noncoding RNA transcription through the KAT2B-H4K8ac-BRD4 axis.
|Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature|2020|0